A Novel Chemotherapeutic Drug Poly-L-Lysine against Cancer Therapy: A Research Based Study

"A Novel Chemotherapeutic Drug Poly-L-Lysine against Cancer Therapy - A Research based Study" offers a fresh perspective on cancer therapy. This research-based study delves into the potential of L-lysine as a novel chemotherapeutic drug that could revolutionize cancer treatment. The authors present the results of their studies which showcase Poly-L-lysine's anti-angiogenesis properties and its potential in treating angiogenesis-related diseases. The book features eleven comprehensive chapters that provide an in-depth analysis of the research including the apoptotic and anticancer effects of L-lysine in mice models as well as its anti-proliferative and antiangiogenic properties. At the same time the book shares fascinating insights about the history of cancer and the medical community's ongoing efforts to find a cure. A Novel Chemotherapeutic Drug Poly-L-Lysine against Cancer Therapy - A Research based Study" is a must-read for anyone interested in the latest advancements in cancer research and the future of cancer therapy.

• | Author: Tapan Kumar Chatterjee
• | Publisher: Pharmamed Press
• | Publication Date: Oct 01, 2025
• | Number of Pages: 204 pages
• | Binding: Hardback or Cased Book
• | ISBN-10: 9390211786
• | ISBN-13: 9789390211784